# Study of INS115644 Ophthalmic Solution in Subjects With Ocular Hypertension or Glaucoma

> **NCT00443924** · PHASE1 · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 56 (actual)

## Conditions studied

- Ocular Hypertension
- Open Angle Glaucoma

## Interventions

- **DRUG:** INS115644 Ophthalmic Solution
- **DRUG:** Placebo
- **DRUG:** INS115644 Ophthalmic Solution
- **DRUG:** INS115644 Ophthalmic Solution
- **DRUG:** INS115644 Ophthalmic Solution

## Key facts

- **NCT ID:** NCT00443924
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-03
- **Primary completion:** 2009-04
- **Final completion:** 2009-04
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2015-01-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00443924

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00443924, "Study of INS115644 Ophthalmic Solution in Subjects With Ocular Hypertension or Glaucoma". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00443924. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*